Speaker Profile
Ph.D., CEO & Founder, Portal
Biography
Armon Sharei, PhD, is the currently the founder and CEO of Portal Biotechnologies - a platform company focused on enabling a new generation of cell therapies and analytics. He was previously the Founder and CEO of SQZ Biotechnologies (NYSE: SQZ), a clinical-stage cell therapy company. During his 10 year tenure, the company raised over $300M in equity financing, established a + $1Bn collaboration with Roche, implemented three oncology clinical trials, and IPOed on the NYSE.Dr. Shareis work on cell engineering has been named as one of Scientific Americans Top 10 World Changing Ideas (2014), Fierce Biotechs Fierce 15 (2015), and a World Economic Forum Technology Pioneer (2017). He has authored over 20 peer-reviewed publications and is the inventor on over 20 patent families.
Talk
Novel Cell Engineering Powered by Portal
Portal will discuss their novel technology that has rapidly gained traction among major biopharma and academic institutions. By dramatically simplifying intracellular delivery, their mechanical delivery technology has enabled novel drug discovery and cell therapy development applications across immune cells, stem cells and other cell types - examples include multiplexed engineering of cells with circular RNA.
Emerging Therapeutics Showcase:
Portal Biotechnologies
Portal is a platform company focused on enabling a new generation of cell therapies and analytics. The mechanoporation technology allows multiplexed delivery of cargo, including RNA, CRISPR, impermeable peptides etc., into immune cells and stem cells while maintaining cell health and function.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
